Form 4: Dare Bioscience Director Receives Stock Units

Dare Bioscience, Inc. reports that Director Gregory W. Matz was granted restricted stock units in lieu of cash compensation for board services.

Summary

• Gregory W. Matz, a Director at Dare Bioscience, Inc., received 30,805 shares of common stock on June 30, 2026.
• These shares were granted as restricted stock units (RSUs) as compensation for his services on the issuer's board of directors and its committees.
• The RSUs represent a contingent right to receive one share of common stock upon vesting.
• The RSUs are scheduled to vest on January 4, 2027.
• Following this transaction, Mr. Matz beneficially owns 30,847 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine compensation event for a director rather than a significant operational or financial development.

Positives

• Director compensation is being structured using equity, aligning the director's interests with shareholders.
• The company is utilizing a common method for compensating board members with equity awards.

Risks

• The value of the RSUs is subject to the future performance of Dare Bioscience's stock price.
• Vesting is contingent on continued service, meaning the director could forfeit the RSUs if they resign before January 4, 2027.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that the use of Restricted Stock Units (RSUs) for director compensation is a standard practice across the biotechnology and pharmaceutical industries, aiming to align executive and director interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The issuance of RSUs represents a form of compensation, which can dilute existing share ownership over time, though it also aligns director incentives with stock performance.
• Employees: This filing does not directly impact employees.

Next Steps

• The restricted stock units will vest on January 4, 2027, at which point the shares will be delivered to Mr. Matz.

Key Dates

Keywords

Dare Bioscience, DARE, Form 4, SEC Filing, Director Compensation, Restricted Stock Units, RSU, Beneficial Ownership, Equity Compensation